A new study suggests that restricting sugar intake during pregnancy and the first two years of a child’s life is associated ...
New findings from the ERS Global Congress on Lung Diseases present a paradigm shift in COPD treatment: Early identification of type 2 inflammation and personalized biologic therapy.
Prior COVID-19 infection was not independently associated with an increased risk for upper respiratory tract infections in adults.
Nirmatrelvir-ritonavir reduced the risk for long COVID in adults aged 50 years and older but not in adolescents.